Nykode Therapeutics AS (OSL: NYKD)

Nykode Therapeutics AS Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 27, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	971	6,988	8,287	23,372	21,356	-
Market Cap Growth	-78.61%	-15.67%	-64.54%	9.44%	-	-
Enterprise Value	-293	5,353	6,040	21,724	21,194	-
Last Close Price	2.97	21.40	28.12	80.70	74.99	-
PE Ratio	-	-	-	-	16.64	-
Forward PE	-	-	23.99	4.32	4.32	-
PS Ratio	18.60	51.73	93.16	74.17	11.55	-
PB Ratio	0.65	4.02	5.36	13.67	13.93	-
P/TBV Ratio	1.00	4.03	5.36	13.67	13.93	-
P/FCF Ratio	-	-	-	9341.31	13.83	-
P/OCF Ratio	-	-	-	2296.91	13.82	-
EV/Sales Ratio	2.05	39.62	67.90	68.94	11.46	-
EV/EBITDA Ratio	-	-	-	-	13.87	-
EV/EBIT Ratio	-	-	-	-	13.87	-
EV/FCF Ratio	0.32	-	-	8682.61	13.72	-
Debt / Equity Ratio	0.03	0.03	0.04	0.04	0.00	0.00
Debt / EBITDA Ratio	-	-	-	-	0.00	-
Debt / FCF Ratio	-	-	-	25.25	0.00	-
Asset Turnover	0.03	0.06	0.04	0.14	1.64	0.06
Quick Ratio	7.96	7.94	5.41	8.12	17.36	7.67
Current Ratio	7.96	8.04	5.43	8.16	17.38	7.68
Return on Equity (ROE)	-27.41%	-21.42%	-24.35%	-5.05%	145.07%	-62.88%
Return on Assets (ROA)	-21.69%	-16.90%	-13.64%	-2.72%	84.59%	-34.29%
Return on Capital (ROIC)	-26.25%	-21.38%	-18.27%	-3.54%	107.72%	-39.92%
Earnings Yield	-26.29%	-5.10%	-5.08%	-0.35%	6.01%	-
FCF Yield	-61.12%	-14.30%	-2.78%	0.01%	7.23%	-
Buyback Yield / Dilution	14.88%	-3.59%	-1.32%	3.31%	-1.14%	-20.80%
Total Shareholder Return	14.88%	-3.59%	-1.32%	3.31%	-1.14%	-20.80%

Source: S&P Capital IQ. Standard template. Financial Sources.